Predictive
Oncology (NASDAQ: POAI) is a developer of highly adaptable assessment
methods for cancer patients to help guide personalized treatments. An article discussing
the company reads, “As part of Predictive Oncology’s commitment to determining
the best pathways for more individualized and effective cancer treatment, one
of its main subsidiaries – Helomics – partnered with the UK 100,000 Genomes
Project (‘UK100K’) in a research study focused on driving precision medicine to
help conquer ovarian cancer. The UK100K initiative couples whole-genome
sequencing of National Health Service (NHS) patients with cancer and other
diseases to rich clinical data on drug treatments and outcomes. Helomics’ study
centers around utilizing this data to continue improving the effectiveness of
its artificial intelligence (AI)-based precision oncology models to drive both
the individualization of therapy (right drug for the right patient) as well as
the discovery of new treatments. Over the long term, Helomics intends to seek
approval to use its precision oncology models as part of the NHS for ovarian
cancer treatment.”
To view the full article, visit http://ibn.fm/mjiQd
About Predictive Oncology Inc.
Predictive Oncology operates in two business areas: first,
applying artificial intelligence to personalized medicine and drug discovery to
provide personalized medicine solutions for patients and clinicians as well as
clients in the pharmaceutical, diagnostic and biotech industries; and second,
production of the FDA-approved STREAMWAY(R) System for automated,
direct-to-drain medical fluid disposal. For more information, visit the
company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates
relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment